News

Editorial

Hereditary stomach cancer

Stomach cancer is the fifth most common cancer in the world, and 10-20% is hereditary

News

GeneMate® now a part of global rare disease database and resource Orphanet

Increased visibility of hereditary cancer risk can lead to increased opportunities for cancer prevention and early detection

News

Job Opening: Clinical Molecular Geneticist

Come join us!

Editorial

What to expect from your GeneMate® test

Editorial

Behind the scenes of GeneMate®

Editorial

The importance of informing family members of a positive result

All first-degree relatives of a carrier have a 50% risk of themselves being a carrier

Editorial

Hereditary melanoma

Melanoma is the most rapidly increasing cancer in Sweden and 10-15% of all cases are hereditary

Editorial

Which genes does GeneMate® test and why?

Our clinically actionable selection of genes gives you a better shot at prevention.

Editorial

Hereditary prostate cancer

1 in 5 Swedish men will be diagnosed with prostate cancer. Guidelines for the identification of hereditary prostate cancer are now expanded.

Editorial

Hereditary cancer: 97% of all carriers remain unidentified

Family history-based testing identifies some, misses many

Editorial

Polyposis syndromes

Polyposis' cause, associated cancer types, and risk-reducing measures

News

iCellate’s lab receives ISO 15189 certification by Swedac

iCellate is the only Swedish company that holds an ISO 15189 certification within cancer diagnostics.

Editorial

Hereditary ovarian cancer

15-20% of all ovarian cancer is hereditary

Editorial

Lynch Syndrome

Lynch syndrom is caused by hereditary pathogenic variants and increases the risk of several different cancer types

Editorial

Things to consider prior to genetic testing

Editorial

This is our mission

Editorial

Hereditary breast cancer

15-20% of all breast cancer is hereditary

 

Editorial

R&D Update: project ELEVATE

Editorial

Hereditary colorectal cancer

One third of all colorectal cancer is hereditary

News

Elthera-led consortium initiates development of novel cancer diagnostics and therapeutics

News

iCellate has been selected to participate in Novartis' Techcare program

News

Study presented at KICancer - StratCan

Research

The early detection of cancer study (ICELLATE1) – published in the Journal of Integrative Oncology

Research

Groundbreaking pan-cancer screening study published

News

iCellate enters partnership with RCC Stockholm-Gotland

News

iCellate Medical closes 15 million SEK second round of funding

News

iCellate Medical receives orders for clinical CTC services from major institutions and adds valuable sequencing competence to the company